CLA-2-29:S:N:N7:238 807432
Brian S. Goldstein, Esq.
Edward B. Ackerman, Esq.
Tompkins & Davidson
One Astor Plaza
1515 Broadway, 43rd Floor
New York, NY 10036-8901
RE: The tariff classification of Salmeterol xinafoate (CAS Reg.
No. 94749-08-3), in bulk form, from England
Gentlemen:
In your letter dated February 23, 1995, on behalf of your
client, Glaxo, Inc., you requested a tariff classification
ruling.
The subject product, Salmeterol xinafoate ("Salmeterol" is
"INN"), which is also known as Salmeterol hydroxynaphthoate, is
used as a bronchodilator and anti-asthma drug.
The applicable subheading for Salmeterol xinafoate - also
known as Salmeterol hydroxynaphthoate - will be 2922.50.2500,
Harmonized Tariff Schedule of the United States (HTS), which
provides for: "Amino-alcohol-phenols, amino-acid-phenols and
other amino-compounds with oxygen function: Aromatic: Other:
Drugs: Other: Other." Pursuant to General Note 13, HTSUSA, the
rate of duty will be free.
This merchandise may be subject to the regulations of the
Food and Drug Administration. You may contact them at 5600
Fishers Lane, Rockville, Maryland 20857, telephone number (301)
443-6553.
This ruling is being issued under the provisions of Section
177 of the Customs Regulations (19 C.F.R. 177).
A copy of this ruling letter should be attached to the entry
documents filed at the time this merchandise is imported. If the
documents have been filed without a copy, this ruling should be
brought to the attention of the Customs officer handling the
transaction.
Sincerely,
Jean F. Maguire
Area Director
New York Seaport